PERRIGO

PRGONYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.986 B

$14.31 +1.27%

Close of 22 Sept 2026

Revenue

$4.25B

#751 by revenue

Earnings

-$1.43B

Loss-making

Shares outstanding

138,769,245

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#111Rapport TherapeuticsRAPP$1.99B
#112Lakefront BiotherapeuticsLKFT$1.99B
#113PERRIGOPRGO$1.99B
#114ZymeworksZYME$1.96B
#115Maravai LifesciencesMRVI$1.94B

What if PERRIGO were worth as much as…

Open the what-if tool →

Gold $30.2T

$217,872.26

Per share 15,225× higher

Bitcoin $1.74T

$12,550.73

Per share 877× higher

Nvidia $5.52T

$39,747.76

Per share 2,778× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for PERRIGO are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.